MedicalResearch.com Interview with:
[caption id="attachment_70752" align="alignleft" width="150"]
Dr. Minji Jung[/caption]
Minji Jung PharmD, PhD
Postdoctoral Research Fellow in Epidemiology
Department of Urology
Stanford University Medical Center
Stanford, CA
MedicalResearch.com: What is the background for this study?
Response: Hypertension is a well-established risk factor for kidney cancer, and previous studies have suggested potential links between antihypertensive medications and kidney cancer risk. However, distinguishing the effects of the medications from those of hypertension itself has been challenging. Our meta-analysis systematically evaluated different classes of antihypertensive drugs while accounting for hypertension.
